drugset / Trial / NCT04857320
Transdermal Insulin Response In Healthy Volunteers
Phase 0
Completed
7 enrolled
Transdermal Delivery Solutions Corp
Langford Research Institute, Inc. · collab
NaSingle-groupOpen-labelDevice feasibility
Summary
Bio-fermentation produced Human insulin is available without prescription in the U.S. This study is a physician-initiated trial of a formula enabling transdermal delivery of human insulin.
Timeline
- Start
- 2021-03-12
- Primary completion
- 2021-11-15
- Completion
- 2021-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | 0.075 iu/kg | Topical |
| Subject | Insulin | Protein / enzyme biologic | 0.1 iu/kg | Topical |
| Subject | Insulin | Protein / enzyme biologic | 0.15 iu/kg | Topical |